02.03.2023 07:05:00
|
Zealand Pharma convenes its Annual General Meeting 2023
Company Announcement – No. 2 / 2023
Zealand convenes its Annual General Meeting 2023 Notice to convene the Annual General Meeting of Zealand Pharma A/S (CVR no. 20 04 50 78) (the "Company"). |
The Board of Directors of the Company hereby convenes the Annual General Meeting of the Company to be held on: |
Wednesday, March 29 2023 at 3:00 pm (CEST) |
The Annual General Meeting will be held as a partly electronic general meeting with the possibility of attending electronically or in person (hybrid meeting). |
The Annual General Meeting will be held electronically via the virtual portal hosted by Computershare A/S, and physically at the Company's registered address Sydmarken 11, DK-2860 Søborg. |
Please find further information in the accompanying attachment. |
Attachment
![](https://ml-eu.globenewswire.com/media/Mjk5NDk2NzItOGU1Ny00MjQxLTkyYTItZjdlODYxM2UzYTI5LTEwMTMyNzQ=/tiny/Zealand-Pharma.png)
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Zealand Pharma A-Smehr Nachrichten
05.02.25 |
Erste Schätzungen: Zealand Pharma A-S gewährt Anlegern Blick in die Bücher (finanzen.net) | |
20.12.24 |
FDA drug rejection hits Zealand Pharma shares (Financial Times) | |
19.12.24 |
U.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome (GlobeNewswire) | |
06.11.24 |
Ausblick: Zealand Pharma A-S legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
23.10.24 |
Erste Schätzungen: Zealand Pharma A-S präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net) | |
14.08.24 |
Ausblick: Zealand Pharma A-S stellt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu Zealand Pharma A-Smehr Analysen
Aktien in diesem Artikel
Zealand Pharma A-S | 97,05 | 0,62% |
|